| regulation of body fluid levels | GO:0050878 | 162 | 0.688 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.449 | |
| amide transport | GO:0042886 | 138 | 0.252 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.230 | |
| response to nutrient levels | GO:0031667 | 109 | 0.186 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.186 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.156 | |
| body fluid secretion | GO:0007589 | 53 | 0.153 | |
| peptide transport | GO:0015833 | 133 | 0.147 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.141 | |
| peptide metabolic process | GO:0006518 | 46 | 0.140 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.139 | |
| gland development | GO:0048732 | 330 | 0.134 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.134 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.128 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.125 | |
| developmental maturation | GO:0021700 | 193 | 0.125 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.124 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.124 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.123 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.123 | |
| placenta development | GO:0001890 | 140 | 0.120 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.119 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.119 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.118 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.116 | |
| lipid transport | GO:0006869 | 98 | 0.114 | |
| isoprenoid metabolic process | GO:0006720 | 29 | 0.112 | |
| response to oxygen levels | GO:0070482 | 62 | 0.112 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.111 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.109 | |
| inflammatory response | GO:0006954 | 244 | 0.108 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.105 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.104 | |
| memory | GO:0007613 | 58 | 0.102 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.100 | |
| regulation of secretion | GO:0051046 | 274 | 0.100 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.099 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.098 | |
| cyclic nucleotide biosynthetic process | GO:0009190 | 44 | 0.096 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.095 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.094 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.094 | |
| organic acid transport | GO:0015849 | 101 | 0.093 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.093 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.093 | |
| connective tissue development | GO:0061448 | 179 | 0.092 | |
| hormone secretion | GO:0046879 | 128 | 0.089 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.089 | |
| regulation of defense response | GO:0031347 | 233 | 0.088 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.088 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.087 | |
| keratinocyte differentiation | GO:0030216 | 48 | 0.084 | |
| carbohydrate transport | GO:0008643 | 62 | 0.083 | |
| skeletal system development | GO:0001501 | 356 | 0.082 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.081 | |
| sensory perception | GO:0007600 | 245 | 0.081 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.079 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.078 | Rat |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.078 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.077 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.077 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.077 | |
| sodium ion transport | GO:0006814 | 73 | 0.076 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.076 | |
| cation transport | GO:0006812 | 399 | 0.076 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.075 | |
| organ or tissue specific immune response | GO:0002251 | 13 | 0.074 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.073 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.073 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.072 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.071 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.071 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.068 | |
| renal sodium excretion | GO:0035812 | 3 | 0.067 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.066 | |
| response to hypoxia | GO:0001666 | 58 | 0.066 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.066 | |
| regulation of appetite | GO:0032098 | 12 | 0.066 | |
| lipid modification | GO:0030258 | 65 | 0.065 | |
| response to inorganic substance | GO:0010035 | 96 | 0.065 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.064 | |
| regulation of ion transport | GO:0043269 | 215 | 0.064 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.063 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.063 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.063 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.063 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.063 | |
| protein maturation | GO:0051604 | 176 | 0.062 | |
| response to acid chemical | GO:0001101 | 111 | 0.062 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.062 | |
| protein processing | GO:0016485 | 163 | 0.062 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.061 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.061 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.061 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.060 | |
| oxidation reduction process | GO:0055114 | 342 | 0.060 | |
| terpenoid metabolic process | GO:0006721 | 25 | 0.060 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.059 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.058 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.058 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.058 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.058 | |
| respiratory tube development | GO:0030323 | 167 | 0.057 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.057 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.057 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.057 | |
| response to peptide | GO:1901652 | 136 | 0.056 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.055 | |
| pituitary gland development | GO:0021983 | 38 | 0.055 | |
| histamine uptake | GO:0051615 | 1 | 0.054 | |
| dephosphorylation | GO:0016311 | 129 | 0.054 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.054 | |
| lactation | GO:0007595 | 25 | 0.053 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.053 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.052 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.052 | |
| organ growth | GO:0035265 | 117 | 0.052 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.052 | |
| amine metabolic process | GO:0009308 | 45 | 0.051 | |
| renal system development | GO:0072001 | 225 | 0.051 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.051 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.051 | |
| retinoic acid metabolic process | GO:0042573 | 12 | 0.050 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.049 | |
| male gamete generation | GO:0048232 | 285 | 0.049 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.048 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.048 | |
| protein catabolic process | GO:0030163 | 221 | 0.048 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.048 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.047 | |
| response to insulin | GO:0032868 | 100 | 0.047 | |
| muscle cell development | GO:0055001 | 133 | 0.047 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.046 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.046 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.046 | |
| hexose metabolic process | GO:0019318 | 98 | 0.046 | |
| fat cell differentiation | GO:0045444 | 160 | 0.046 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.046 | |
| monosaccharide transport | GO:0015749 | 58 | 0.045 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.045 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.045 | |
| cell maturation | GO:0048469 | 127 | 0.045 | |
| urate transport | GO:0015747 | 1 | 0.045 | |
| metanephros development | GO:0001656 | 79 | 0.045 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.044 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.044 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.044 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.044 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.044 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.044 | |
| endocytosis | GO:0006897 | 168 | 0.044 | |
| tissue homeostasis | GO:0001894 | 115 | 0.044 | |
| defense response to other organism | GO:0098542 | 197 | 0.043 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.043 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.042 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.042 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.042 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.042 | |
| transmembrane transport | GO:0055085 | 412 | 0.042 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.042 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.041 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.041 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.041 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.041 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.041 | |
| renal system process | GO:0003014 | 48 | 0.041 | |
| retinoid metabolic process | GO:0001523 | 24 | 0.041 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.040 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.040 | |
| bone development | GO:0060348 | 120 | 0.040 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.040 | |
| clara cell differentiation | GO:0060486 | 4 | 0.040 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.040 | |
| urogenital system development | GO:0001655 | 261 | 0.040 | |
| regulation of timing of cell differentiation | GO:0048505 | 11 | 0.040 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.039 | |
| lipid oxidation | GO:0034440 | 29 | 0.039 | |
| regulation of cell motility | GO:2000145 | 236 | 0.039 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.039 | |
| g protein coupled receptor internalization | GO:0002031 | 3 | 0.039 | |
| hair follicle development | GO:0001942 | 85 | 0.039 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.038 | |
| response to peptide hormone | GO:0043434 | 127 | 0.038 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.038 | |
| intestinal absorption | GO:0050892 | 13 | 0.038 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.038 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.038 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.038 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.038 | |
| neural tube development | GO:0021915 | 160 | 0.038 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.038 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.037 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.037 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.037 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.037 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.037 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.037 | |
| lipid localization | GO:0010876 | 126 | 0.036 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.036 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.036 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.036 | |
| rhythmic process | GO:0048511 | 174 | 0.036 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.036 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.036 | |
| humoral immune response | GO:0006959 | 57 | 0.035 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.035 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.035 | |
| positive regulation of ras gtpase activity | GO:0032320 | 65 | 0.035 | |
| skin development | GO:0043588 | 220 | 0.035 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.035 | |
| anion transport | GO:0006820 | 177 | 0.034 | |
| lung induction | GO:0060492 | 3 | 0.034 | |
| cellular homeostasis | GO:0019725 | 240 | 0.034 | |
| lung development | GO:0030324 | 164 | 0.034 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.034 | |
| response to starvation | GO:0042594 | 65 | 0.034 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.034 | |
| jnk cascade | GO:0007254 | 72 | 0.034 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.034 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.034 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.034 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.033 | |
| epidermis development | GO:0008544 | 187 | 0.033 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.033 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.032 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.032 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.032 | |
| hexose transport | GO:0008645 | 56 | 0.032 | |
| tissue migration | GO:0090130 | 68 | 0.032 | |
| epithelial cell development | GO:0002064 | 159 | 0.032 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.032 | |
| negative regulation of behavior | GO:0048521 | 14 | 0.032 | |
| regulation of saliva secretion | GO:0046877 | 2 | 0.032 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.032 | |
| mammary gland lobule development | GO:0061377 | 22 | 0.032 | |
| endocrine system development | GO:0035270 | 98 | 0.031 | |
| cell adhesion | GO:0007155 | 329 | 0.031 | |
| glucose transport | GO:0015758 | 56 | 0.031 | |
| organic anion transport | GO:0015711 | 137 | 0.031 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.031 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.031 | |
| response to drug | GO:0042493 | 75 | 0.031 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.031 | |
| mapk cascade | GO:0000165 | 281 | 0.031 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.030 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.030 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.030 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.030 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.030 | |
| sterol homeostasis | GO:0055092 | 45 | 0.030 | |
| regulation of epidermis development | GO:0045682 | 33 | 0.030 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.030 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.030 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.030 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.030 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.030 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.030 | |
| diencephalon development | GO:0021536 | 63 | 0.030 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.030 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.029 | |
| tube formation | GO:0035148 | 140 | 0.029 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.029 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.029 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.029 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.029 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.029 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.029 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.028 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.028 | |
| regulation of binding | GO:0051098 | 111 | 0.028 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.028 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.028 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.028 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.028 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.028 | |
| regulation of protein transport | GO:0051223 | 163 | 0.028 | |
| antibacterial humoral response | GO:0019731 | 8 | 0.028 | |
| forebrain development | GO:0030900 | 302 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.028 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.028 | |
| midgut development | GO:0007494 | 4 | 0.028 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.028 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.028 | |
| protein localization to organelle | GO:0033365 | 185 | 0.027 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.027 | |
| spermatogenesis | GO:0007283 | 284 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.027 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.027 | |
| prostate gland development | GO:0030850 | 48 | 0.027 | |
| lipid homeostasis | GO:0055088 | 63 | 0.027 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.027 | |
| respiratory system development | GO:0060541 | 190 | 0.027 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.027 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.027 | |
| mucosal immune response | GO:0002385 | 13 | 0.027 | |
| intestinal epithelial cell maturation | GO:0060574 | 2 | 0.027 | |
| spleen development | GO:0048536 | 39 | 0.027 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.027 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.026 | |
| intestinal epithelial cell differentiation | GO:0060575 | 14 | 0.026 | |
| steroid metabolic process | GO:0008202 | 119 | 0.026 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.026 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.026 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.026 | |
| fat soluble vitamin metabolic process | GO:0006775 | 11 | 0.026 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.026 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.026 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.026 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.026 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.026 | |
| angiogenesis | GO:0001525 | 201 | 0.026 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.026 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.026 | |
| myotube differentiation | GO:0014902 | 105 | 0.026 | |
| ossification | GO:0001503 | 216 | 0.026 | |
| circadian rhythm | GO:0007623 | 114 | 0.026 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.026 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.025 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.025 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.025 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.025 | |
| hippocampus development | GO:0021766 | 52 | 0.025 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.025 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.025 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.025 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.025 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.025 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.025 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.025 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.025 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.025 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.025 | |
| oviduct development | GO:0060066 | 3 | 0.025 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.024 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.024 | |
| somatostatin receptor signaling pathway | GO:0038169 | 2 | 0.024 | |
| cellular divalent inorganic anion homeostasis | GO:0072501 | 3 | 0.024 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.024 | |
| cyclic purine nucleotide metabolic process | GO:0052652 | 43 | 0.024 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.024 | |
| epinephrine transport | GO:0048241 | 1 | 0.024 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.024 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.024 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.024 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.024 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.024 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.024 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.024 | |
| keratinocyte proliferation | GO:0043616 | 21 | 0.024 | |
| cgmp biosynthetic process | GO:0006182 | 13 | 0.024 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.024 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.024 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.024 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.024 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.023 | |
| monoamine transport | GO:0015844 | 33 | 0.023 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.023 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.023 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.023 | |
| planar cell polarity pathway involved in heart morphogenesis | GO:0061346 | 3 | 0.023 | |
| diacylglycerol biosynthetic process | GO:0006651 | 2 | 0.023 | |
| camera type eye development | GO:0043010 | 266 | 0.023 | |
| glucose homeostasis | GO:0042593 | 128 | 0.023 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.023 | |
| endocrine process | GO:0050886 | 39 | 0.023 | |
| regulation of antimicrobial peptide biosynthetic process | GO:0002805 | 1 | 0.023 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.023 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.023 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.023 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.023 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.023 | |
| cgmp metabolic process | GO:0046068 | 20 | 0.023 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.023 | |
| wound healing | GO:0042060 | 157 | 0.023 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.023 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.022 | |
| regulation of jnk cascade | GO:0046328 | 62 | 0.022 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.022 | |
| histamine induced gastric acid secretion | GO:0001697 | 1 | 0.022 | |
| positive regulation of growth hormone secretion | GO:0060124 | 3 | 0.022 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.022 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.022 | |
| gtp metabolic process | GO:0046039 | 144 | 0.022 | |
| sensory perception of pain | GO:0019233 | 47 | 0.022 | |
| adenohypophysis development | GO:0021984 | 14 | 0.022 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.022 | |
| intracellular protein transport | GO:0006886 | 204 | 0.022 | |
| foregut regionalization | GO:0060423 | 3 | 0.022 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.022 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.022 | |
| hair cycle | GO:0042633 | 90 | 0.022 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.022 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.022 | |
| lung alveolus development | GO:0048286 | 45 | 0.022 | |
| trabecula morphogenesis | GO:0061383 | 40 | 0.022 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.022 | |
| response to metal ion | GO:0010038 | 47 | 0.022 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.022 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.021 | |
| establishment of skin barrier | GO:0061436 | 14 | 0.021 | |
| gtp catabolic process | GO:0006184 | 143 | 0.021 | |
| epithelial cell migration | GO:0010631 | 63 | 0.021 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.021 | |
| negative regulation of growth | GO:0045926 | 99 | 0.021 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.021 | |
| lung field specification | GO:0060424 | 3 | 0.021 | |
| mammary gland branching involved in pregnancy | GO:0060745 | 6 | 0.021 | |
| muscle tissue development | GO:0060537 | 308 | 0.021 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.021 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.021 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.021 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.021 | |
| innate immune response in mucosa | GO:0002227 | 3 | 0.021 | |
| salivary gland development | GO:0007431 | 37 | 0.021 | |
| peptide biosynthetic process | GO:0043043 | 11 | 0.021 | |
| biomineral tissue development | GO:0031214 | 64 | 0.021 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.021 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.021 | |
| establishment of endothelial blood brain barrier | GO:0014045 | 3 | 0.021 | |
| bronchiole development | GO:0060435 | 3 | 0.020 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.020 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.020 | |
| gas homeostasis | GO:0033483 | 3 | 0.020 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.020 | |
| hindbrain formation | GO:0021576 | 1 | 0.020 | |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.020 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.020 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.020 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.020 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.020 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.020 | |
| protein ubiquitination | GO:0016567 | 171 | 0.020 | |
| peptide secretion | GO:0002790 | 114 | 0.020 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.020 | |
| cellular phosphate ion homeostasis | GO:0030643 | 2 | 0.020 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 71 | 0.020 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.020 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.020 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.020 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.020 | |
| renal outer medulla development | GO:0072054 | 2 | 0.019 | |
| regulation of cardiac muscle cell proliferation | GO:0060043 | 23 | 0.019 | |
| circulatory system process | GO:0003013 | 197 | 0.019 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.019 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.019 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.019 | |
| left lung development | GO:0060459 | 4 | 0.019 | |
| pulmonary myocardium development | GO:0003350 | 3 | 0.019 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.019 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.019 | |
| fibroblast proliferation | GO:0048144 | 35 | 0.019 | |
| regulation of vitamin metabolic process | GO:0030656 | 3 | 0.019 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.019 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.019 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.019 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.018 | |
| regulation of camp biosynthetic process | GO:0030817 | 25 | 0.018 | |
| gonad development | GO:0008406 | 141 | 0.018 | |
| kidney development | GO:0001822 | 213 | 0.018 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.018 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.018 | |
| digestive tract development | GO:0048565 | 190 | 0.018 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.018 | |
| cardiac chamber development | GO:0003205 | 108 | 0.018 | |
| response to water deprivation | GO:0009414 | 1 | 0.018 | |
| ventral spinal cord interneuron fate determination | GO:0060580 | 1 | 0.018 | |
| regulation of cell migration | GO:0030334 | 219 | 0.018 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.018 | |
| lung secretory cell differentiation | GO:0061140 | 13 | 0.018 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.018 | |
| water homeostasis | GO:0030104 | 27 | 0.018 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.018 | |
| cytokine secretion | GO:0050663 | 72 | 0.018 | |
| positive regulation of rho gtpase activity | GO:0032321 | 41 | 0.018 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.018 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.018 | |
| regulation of organ growth | GO:0046620 | 61 | 0.018 | |
| male sex differentiation | GO:0046661 | 109 | 0.018 | |
| positive regulation of nucleotide biosynthetic process | GO:0030810 | 26 | 0.017 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.017 | |
| fertilization | GO:0009566 | 127 | 0.017 | |
| mating | GO:0007618 | 27 | 0.017 | |
| positive regulation of renal sodium excretion | GO:0035815 | 2 | 0.017 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.017 | |
| regulation of cell size | GO:0008361 | 72 | 0.017 | |
| neuron death | GO:0070997 | 154 | 0.017 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.017 | |
| trabecula formation | GO:0060343 | 24 | 0.017 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.017 | |
